Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Medarex, Inc. - Financial and Strategic Analysis Review

157 views

Published on

Medarex, Inc. - Financial and Strategic Analysis ReviewSummaryMedarex, Inc. (Medarex) is a biopharmaceutical company focused on the development and commercialization of fully therapeutic products in the therapeutic areas of oncology, inflammation, autoimmune disorders and infectious diseases. Medarex's UltiMAb technology is used in product development. With the use of the technology, Medarex is generating, supporting and commercializing number of fully human antibody drugs. Medarex has a wide product pipeline of 34 antibodies obtained from Medarex technology, with six product candidates in phase III clinical trials. In addition, the company has several product candidates in pre-clinical development.Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Medarex, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.Scope' The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered. ' The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted. ' The report contains critical company information ' business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.' It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.' Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.Reasons to buy' A quick 'one-stop-shop' to understand the company. ' Enhance business/sales activities by understanding customers' businesses better.' Get detailed information and financial & strategic analysis on companies operating in your industry.' Identify prospective partners and suppliers ' with key data on their businesses and locations.' Capitalize on competitors' weaknesses and target the market opportunities available to them.' Compare your company's financial trends with those of your peers / competitors.' Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Published in: Business, Economy & Finance
  • Be the first to comment

  • Be the first to like this

Medarex, Inc. - Financial and Strategic Analysis Review

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Medarex, Inc. - Financial and Strategic Analysis ReviewPublished on February 2009 Report SummaryMedarex, Inc. - Financial and Strategic Analysis ReviewSummaryMedarex, Inc. (Medarex) is a biopharmaceutical company focused on the development and commercialization of fully therapeuticproducts in the therapeutic areas of oncology, inflammation, autoimmune disorders and infectious diseases. Medarexs UltiMAbtechnology is used in product development. With the use of the technology, Medarex is generating, supporting and commercializingnumber of fully human antibody drugs. Medarex has a wide product pipeline of 34 antibodies obtained from Medarextechnology, with six product candidates in phase III clinical trials. In addition, the company has several product candidates inpre-clinical development.Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis ofMedarex, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executivebiographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Directs views on thecompany.Scope The companys strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operationalfactors are considered. The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats arehighlighted. The report contains critical company information business structure and operations, the company history, major products andservices, key competitors, key employees and executive biographies, different locations and important subsidiaries. It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters. Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.Reasons to buy A quick one-stop-shop to understand the company. Enhance business/sales activities by understanding customers businesses better. Get detailed information and financial & strategic analysis on companies operating in your industry. Identify prospective partners and suppliers with key data on their businesses and locations. Capitalize on competitors weaknesses and target the market opportunities available to them. Compare your companys financial trends with those of your peers / competitors. Scout for potential acquisition targets, with detailed insight into the companies strategic, financial and operational performance.Medarex, Inc. - Financial and Strategic Analysis Review Page 1/5
  2. 2. Find Industry reports, Company profilesReportLinker and Market Statistics Table of ContentTable Of ContentsKey Information 1Key Ratios 1Share Data 1Performance Chart 1Key Facts 3Major Products and Services 4Overview 4History 5SWOT Analysis Overview 6Overview 6Medarex, Inc. - Strengths 6Intellectual Property 6Ipilimumab 6UltiMAb Technology 6Medarex, Inc. - Weaknesses 6Continuous Net Losses 6Negative Impact of Equity Stake in Celldex 6Dependence on the Contract Agreements for Commercialization 6Medarex, Inc. - Opportunities 6Growing Cancer Market 6Milestone Payments 7Collaboration with BioWa, Inc. 7Emerging Markets 7Medarex, Inc. - Threats 7Reimbursement and Pricing Controls 7Intense Competition and Rapid Technological Changes 7Pending Litigations 7Tightening of the FDAs Regulatory Oversight 7Impact of the Financial Crisis 7Industry Consolidation 8Key Competitors 8Key Employees 8Company Statement 9Locations And Subsidiaries 10Head Office 10Other Locations & Subsidiaries 10Financial Ratios 11Capital Market Ratios 11Annual Ratios 12Interim Ratios 13Ratio Charts 14Appendix 15Methodology 15Ratio Definitions 15Medarex, Inc. - Financial and Strategic Analysis Review Page 2/5
  3. 3. Find Industry reports, Company profilesReportLinker and Market StatisticsAbout Global Markets Direct 18Contact Us 18Disclaimer 18List of TablesMedarex, Inc., Key Facts, 2006 1Medarex, Inc., Key Ratios 1Medarex, Inc., Share Data 1Medarex, Inc., Key Facts 3Major Products and Services 4Medarex, Inc., History 5Currency Codes 15Capital Market Ratios 15Equity Ratios 16These ratios are based on per share value. 16Profitability Ratios 16Cost Ratios 17Liquidity Ratios 17Leverage Ratios 17Efficiency Ratios 18List of FiguresMedarex, Inc., Performance Chart (2003 - 2007) 1Medarex, Inc., Ratio Charts 14Medarex, Inc. - Financial and Strategic Analysis Review Page 3/5
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Medarex, Inc. - Financial and Strategic Analysis Review Product Formats Please select the product formats and the quantity you require. Digital Copy--USD 125.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Medarex, Inc. - Financial and Strategic Analysis Review Page 4/5
  5. 5. Find Industry reports, Company profilesReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Medarex, Inc. - Financial and Strategic Analysis Review Page 5/5

×